190 related articles for article (PubMed ID: 1786471)
1. Recombinant antihemophilic factors.
Kurachi K
Biotechnology; 1991; 19():177-95. PubMed ID: 1786471
[No Abstract] [Full Text] [Related]
2. Recombinant blood clotting proteins for hemophilia therapy.
Limentani SA; Roth DA; Furie BC; Furie B
Semin Thromb Hemost; 1993; 19(1):62-72. PubMed ID: 8456325
[No Abstract] [Full Text] [Related]
3. Recombinant clotting factor concentrates.
Lusher JM
Baillieres Clin Haematol; 1996 Jun; 9(2):291-303. PubMed ID: 8800506
[No Abstract] [Full Text] [Related]
4. Hereditary hemorrhagic disorders.
Batlle J; Scandella D; Savidge G
Rev Invest Clin; 1994 Apr; Suppl():134-43. PubMed ID: 7886297
[No Abstract] [Full Text] [Related]
5. [Coagulation factors. Indications and applications].
Stampfli K; Hartmann S
Ther Umsch; 1984 Aug; 41(8):571-5. PubMed ID: 6437000
[No Abstract] [Full Text] [Related]
6. [Reflections on the use of PPSB fraction (Prothrombin-proconvertin-Stuart factor-antihemophilic factor B)].
Malinvaud G
Transfusion (Paris); 1966; 9(3):245-54. PubMed ID: 5969560
[No Abstract] [Full Text] [Related]
7. The molecular genetics of hemophilia.
Lawn RM; Vehar GA
Sci Am; 1986 Mar; 254(3):48-54. PubMed ID: 3006240
[No Abstract] [Full Text] [Related]
8. Editorial: Factor VIII inhibitors.
Deykin D
N Engl J Med; 1974 Jul; 291(4):205. PubMed ID: 4834491
[No Abstract] [Full Text] [Related]
9. Molecular biology of coagulation.
Pavirani A; Bischoff R
Schweiz Med Wochenschr Suppl; 1991; 43():55-7. PubMed ID: 1843038
[No Abstract] [Full Text] [Related]
10. Surgery in haemophilic patients with inhibitors.
Rodriguez-Merchan EC
Haemophilia; 2004 Sep; 10 Suppl 2():1-2. PubMed ID: 15385039
[No Abstract] [Full Text] [Related]
11. [Blood plasma fractions for the management of coagulation disorders: 3. The P.P.S.B. fraction].
Richter K; Klingenberg K; Reinecke D
Z Gesamte Inn Med; 1968 Jan; 23(1):18-21. PubMed ID: 5662427
[No Abstract] [Full Text] [Related]
12. [Concentrated antihemophilic globulin in the treatment of hemorrhagic syndromes].
Baklaja F; Cvetković V; Stajić M; Krivokapić L
Bilt Hematol Transfuz; 1976; 4(3):61-6. PubMed ID: 1008799
[TBL] [Abstract][Full Text] [Related]
13. Activated prothrombin concentrate for patients with factor VIII inhibitors.
Kurczynski EM; Penner JA
N Engl J Med; 1974 Jul; 291(4):164-7. PubMed ID: 4834485
[No Abstract] [Full Text] [Related]
14. Hereditary disorders of blood coagulation.
Zieve PD; Levin J
Major Probl Intern Med; 1976; 10():51-64. PubMed ID: 785116
[No Abstract] [Full Text] [Related]
15. The promise of third-generation recombinant therapy and gene therapy.
Manno CS
Semin Hematol; 2003 Jul; 40(3 Suppl 3):23-8. PubMed ID: 14690065
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.
Collins PW; Chalmers E; Hart DP; Liesner R; Rangarajan S; Talks K; Williams M; Hay CR;
Br J Haematol; 2013 Jan; 160(2):153-70. PubMed ID: 23157203
[No Abstract] [Full Text] [Related]
17. Production of recombinant coagulation proteins.
Vehar GA
Ann N Y Acad Sci; 1987; 509():82-8. PubMed ID: 3122622
[No Abstract] [Full Text] [Related]
18. Current status of hemophilia patients and recombinant coagulation factor concentrates in Japan.
Fukutake K
Semin Thromb Hemost; 2000; 26(1):29-32. PubMed ID: 10805278
[TBL] [Abstract][Full Text] [Related]
19. Gene transfer as an approach to cure patients with hemophilia A or B.
Thompson AR; Palmer TD; Lynch CM; Miller AD
Curr Stud Hematol Blood Transfus; 1991; (58):59-62. PubMed ID: 1954775
[No Abstract] [Full Text] [Related]
20. [Substitution therapy with factor 8 and factor IX preparations].
Landbeck G
Hamatol Bluttransfus; 1968; 5():29-42. PubMed ID: 5729465
[No Abstract] [Full Text] [Related]
[Next] [New Search]
